Esperion Therapeutics
ESPR
#7789
Rank
NZ$0.44 B
Marketcap
$2.24
Share price
-6.47%
Change (1 day)
-53.55%
Change (1 year)

Esperion Therapeutics (ESPR) - Total liabilities

Total liabilities on the balance sheet as of December 2024 : NZ$1.26 Billion

According to Esperion Therapeutics's latest financial reports the company's total liabilities are NZ$1.26 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Esperion Therapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2024-12-31NZ$1.29 B24.31%
2023-12-31NZ$1.04 B16.04%
2022-12-31NZ$0.90 B6.31%
2021-12-31NZ$0.84 B35.99%
2020-12-31NZ$0.62 B115.66%
2019-12-31NZ$0.28 B201.11%
2018-12-31NZ$95.9 M105.51%
2017-12-31NZ$46.66 M94.61%
2016-12-31NZ$23.98 M97.43%
2015-12-31NZ$12.14 M-2.11%
2014-12-31NZ$12.4 M142.6%
2013-12-31NZ$5.11 M-82.97%
2012-12-31NZ$30.02 M184.53%
2011-12-31NZ$10.55 M
2002-12-31NZ$24.19 M-15.15%
2001-12-31NZ$28.51 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
NZ$2.13 B 69.43%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$2.29 B 81.69%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$215.31 B 16,950.06%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$14.49 B 1,047.48%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$1.01 B-19.32%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.26 B-79.19%๐Ÿ‡บ๐Ÿ‡ธ USA